Morning Briefing
Summaries of health policy coverage from major news organizations
Demand For $84,000 Hepatitis C Drug Slows
Health care providers may be waiting for other, soon-to-be-released drugs to treat hepatitis C. Also, an Indian pharmaceutical company faces Justice Department questions on pricing data for Medicaid.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
